Show simple item record

dc.contributor.authorShargh, SA
dc.contributor.authorMovafagh, A
dc.contributor.authorZarghami, N
dc.contributor.authorSayad, A
dc.contributor.authorMansouri, N
dc.contributor.authorTaheri, M
dc.contributor.authorPour, AH
dc.contributor.authorIranpour, M
dc.contributor.authorGhaedi, H
dc.contributor.authorMontazeri, V
dc.contributor.authorMassoudi, N
dc.contributor.authorHashemi, M
dc.contributor.authorMortazavi-Tabatabaei, SA
dc.date.accessioned2018-08-26T08:51:32Z
dc.date.available2018-08-26T08:51:32Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53437
dc.description.abstractBreast cancer is the most prevalent type of cancer among women around the world, and mortality is primarily caused by micro-metastatic disease. The complex mechanisms of breast cancer invasion and metastasis are intrinsically related to the malignant cell type so that early detection of micro-metastases can help prolongation of survival for patient. The aim of the present research work was evaluation of the expression status of mammoglobin protein as a candidate molecular marker in the negative sentinel lymph node (SLN). Fifty tumor specimens, and 50 normal adjacent breast tissue samples from the same patients were selected on the basis of having more than 10% tumor content for RNA extraction from SLNs. Tumor samples and normal adjacent breast tissue were archived in the form of frozen fresh tissue in liquid nitrogen. Real-time PCR was performed on a Bioner life express gradient thermal cycler system. Mammoglobin gene overexpression in breast cancer metastasis was investigated. Single marker results were mammaglobin 66.7% and CK19 50.0%, with 58.3% for the two in combination. Due to improved outcome with at least 3 genes (83.3%), it seems, triple marker evaluation will be most likely useful for detecting micro-metastases instead of studying separate genes. é 2016, Asian Pacific Journal of Cancer Prevention.
dc.language.isoEnglish
dc.relation.ispartofAsian Pacific Journal of Cancer Prevention
dc.subjecttumor marker
dc.subjecttumor protein
dc.subjectBreast Neoplasms
dc.subjectcase control study
dc.subjectcomparative study
dc.subjectearly cancer diagnosis
dc.subjectfemale
dc.subjectfollow up
dc.subjectgenetics
dc.subjecthuman
dc.subjectlymph node metastasis
dc.subjectmetabolism
dc.subjectmicrometastasis
dc.subjectpathology
dc.subjectprognosis
dc.subjectreal time polymerase chain reaction
dc.subjectsentinel lymph node
dc.subjectBiomarkers, Tumor
dc.subjectBreast Neoplasms
dc.subjectCase-Control Studies
dc.subjectEarly Detection of Cancer
dc.subjectFemale
dc.subjectFollow-Up Studies
dc.subjectHumans
dc.subjectLymphatic Metastasis
dc.subjectNeoplasm Micrometastasis
dc.subjectNeoplasm Proteins
dc.subjectPrognosis
dc.subjectReal-Time Polymerase Chain Reaction
dc.subjectSentinel Lymph Node
dc.titleDetection of superior markers for polymerase chain reaction diagnosis of breast cancer micrometastasis in sentinel lymph nodes
dc.typeArticle
dc.citation.volume17
dc.citation.spage179
dc.citation.epage183
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.7314/APJCP.2016.17.S3.179


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record